trastuzumab
SpainDrugs containing this active substance
-
It is used for the treatment of breast cancer (early or metastatic) and metastatic gastric cancer, provided that high levels of a protein called HER2 are present.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg Manufacturer: Roche Registration Gmbh
-
It is prescribed for the treatment of early or metastatic breast cancer in patients who have high levels of a protein called HER2.
Form: solution for injection
Active substance Dosage trastuzumab 600 mg Manufacturer: Roche Registration Gmbh
-
It is prescribed for the treatment of early or metastatic breast cancer, and metastatic gastric cancer, provided they show high levels of a protein called HER2.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used to treat early or metastatic breast cancer and metastatic gastric cancer, provided that the tumor cells have high levels of a protein called HER2.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used for the treatment of breast cancer (early or metastatic) and metastatic gastric cancer, provided that the tumor cells have high levels of a protein called HER2.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 156 mg Manufacturer: Amgen Europe B.V.
-
It is used to treat early or metastatic breast cancer and metastatic gastric cancer, provided that the tumor cells have high levels of a protein called HER2.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 440 mg Manufacturer: Amgen Europe B.V.
-
It is prescribed for the treatment of early or metastatic breast cancer, and metastatic gastric cancer, provided that the tumor cells have high levels of a protein called HER2.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg Manufacturer: Biosimilar Collaborations Ireland Limited
-
It is prescribed for the treatment of early or metastatic breast cancer, and metastatic gastric cancer, provided they show high levels of the HER2 protein.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg Manufacturer: Biosimilar Collaborations Ireland Limited
-
It is used to treat early or metastatic breast cancer, as well as metastatic gastric cancer, provided they exhibit high levels of the HER2 protein.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is prescribed for the treatment of breast cancer (either early or metastatic) or metastatic gastric cancer, provided that high levels of the HER2 protein are present.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is used to treat adult patients with HER2-positive breast cancer, either when the cancer has spread to other parts of the body or when treatment is needed before or after surgery.
Form: solution for injection
Active substance Dosage pertuzumab 1200 mg trastuzumab 600 mg Manufacturer: Roche Registration Gmbh
-
It is used to treat adult patients with HER2-positive breast cancer, either when the cancer has spread to other parts of the body or when treatment is required before or after surgery.
Form: solution for injection
Active substance Dosage pertuzumab 600 mg trastuzumab 600 mg Manufacturer: Roche Registration Gmbh
-
It is prescribed to treat early or metastatic breast cancer, and metastatic gastric cancer, provided they show high levels of a protein called HER2.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is prescribed to treat breast cancer (early or metastatic) and metastatic gastric cancer, provided that the tumor cells show high levels of a protein called HER2.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is prescribed to treat early or metastatic breast cancer, and metastatic gastric cancer, provided that high levels of a protein called HER2 are present.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg Manufacturer: Accord Healthcare S.L.U.
-
It is prescribed for the treatment of breast cancer (early or metastatic) and metastatic gastric cancer, provided that high levels of a protein called HER2 are present.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg Manufacturer: Accord Healthcare S.L.U.
-
It is prescribed for the treatment of breast cancer (early or metastatic) and metastatic gastric cancer, provided that high levels of a protein called HER2 are present.
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 60 mg Manufacturer: Accord Healthcare S.L.U.